Bioequivalence Study to Compare Two Formulations of Deanxit®

NCT03472651 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: test treatment: flupentixol/melitracen
DRUG: reference treatment: flupentixol/melitracen

Sponsor

H. Lundbeck A/S